Cargando…
Details of risk–benefit communication in informed consent documents for phase I/II trials
BACKGROUND: Informed consent documents for clinical studies should disclose all reasonably foreseeable risks and benefits. Little guidance exists on how to navigate the complexities of risk–benefit communication, especially in early clinical research. Practice-oriented development of such guidance s...
Autores principales: | Kahrass, Hannes, Bossert, Sabine, Schürmann, Christopher, Strech, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876653/ https://www.ncbi.nlm.nih.gov/pubmed/33231107 http://dx.doi.org/10.1177/1740774520971770 |
Ejemplares similares
-
Participatory improvement of a template for informed consent documents in biobank research - study results and methodological reflections
por: Bossert, Sabine, et al.
Publicado: (2017) -
An instrument for assessing the quality of informed consent documents for elective procedures: development and testing
por: Spatz, Erica S, et al.
Publicado: (2020) -
Informed Consent Documentation for Lumbar Puncture in the Emergency Department
por: Patel, Pankaj B., et al.
Publicado: (2014) -
Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
por: Munung, Nchangwi Syntia, et al.
Publicado: (2016) -
Informed Consent in Aesthetic Surgery
por: Kapoor, Lalit
Publicado: (2015)